Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
53,260,910
-
Share change
-
+8,427,211
-
Total reported value
-
$1,329,650,614
-
Put/Call ratio
-
255%
-
Price per share
-
$24.97
-
Number of holders
-
141
-
Value change
-
+$210,595,949
-
Number of buys
-
100
-
Number of sells
-
41
Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) as of Q2 2016
As of 30 Jun 2016,
ALDER BIOPHARMACEUTICALS INC - COM (ALDR) was held by
141 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,260,910 shares.
The largest 10 holders included
FMR LLC, JANUS CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, Partner Fund Management, L.P., VANGUARD GROUP INC, BlackRock Fund Advisors, Cormorant Asset Management, LLC, BB BIOTECH AG, Foresite Capital Management III, LLC, and ALLIANCEBERNSTEIN L.P..
This page lists
141
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.